Characterization of bitiscetin-2, a second form of bitiscetin from the venom of Bitis arietans: Comparison of its binding site with the collagen-binding site on the von Willebrand factor A3-domain

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 7, 2006, Pages 1596-1601

  Obert, B ^a   Romijn, R A ^b,c   Houllier, A ^a   Huizinga, E G ^d   Girma, Jean Pierre ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

A3 domain; Bitiscetin 2; Collagen binding; Mutants; Von Willebrand factor

Indexed keywords

ARGININE; ASPARTIC ACID; BITIS ARIETANS VENOM; BITISCETIN 2; COLLAGEN; COLLAGEN TYPE 3; GLUTAMIC ACID; HISTIDINE; ISOLEUCINE; PROLINE; RECOMBINANT PROTEIN; SERINE; SNAKE VENOM; UNCLASSIFIED DRUG; VALINE; VON WILLEBRAND FACTOR;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CONTROLLED STUDY; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; SNAKE; THROMBOCYTE;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; COLLAGEN; PEPTIDES; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; POINT MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; VIPER VENOMS; VIPERIDAE; VON WILLEBRAND FACTOR;

EID: 33745244127     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01994.x     Document Type: Article

References (24)

1. Sadler JE. Biochemistry and genetics of von Willebrand factor. Ann Rev Biochem 1998; 67: 395-424.
2. Siedlecki CA, Eppell SJ, Marchant RE. Interactions of human von Willebrand factor with a hydrophobic self-assembled monolayer studied by atomic force microscopy. J Bio Mater Res 1994; 28: 971-80.
3. Brinkhous KM, Read MS, Fricke WA, Wagner RH. Botrocetin (venom coagglutinin): Reaction with a broad spectrum of multimeric forms of factor VIII macromolecular complex. Proc Natl Acad Sci USA 1983; 80: 1463-6.
4. Hamako J, Matsui T, Suzuki M, Ito M, Makita K, Fujimura Y, Ozeki Y, Titani K. Purification and characterization of bitiscetin, a novel von Willebrand factor modulator protein from Bitis arietans snake venom. Biochem Biophys Res Commun 1996; 226: 273-9.
5. Obert B, Houllier A, Meyer D, Girma JP. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib. Blood 1999; 93: 1959-68.
6. Chopek MW, Girma JP, Fujikawa K, Davie EW, Titani K. Willebrand Factor: a multivalent protein composed of identical subunits. Biochemistry 1986; 25: 3146-55.
7. Titani K, Kumar S, Ericsson LH, Wade RD, Ashida K, Walsh KA, Chopek MW, Sadler JE, Fujikawa K. Amino acid sequence of human von Willebrand Factor. Biochemistry 1986; 25: 3171-84.
8. Kalafatis M, Takahashi Y, Girma JP, Meyer D. Localization of a collagen-interactive domain of human von Willebrand Factor between amino acid residues Gly 911 and Glu 1365. Blood 1987; 70: 1577-83.
9. Pareti FI, Niiya K, McPherson JM, Ruggeri ZM. Isolation and characterization of two domains of human von Willebrand Factor that interact with fibrillar collagen types I and III. J Biol Chem 1987; 262: 13835-41.
10. Lankhof H, van Hoeij M, Schiphorst ME, Bracke M, Wu YP, Ijsseldijk MJ, Vink T, de Groot PG, Sixma JJ. A3 domain is essential for interaction of von Willebrand factor with collagen type III. Thromb Haemost 1996; 7: 950-8.
11. Cruz MA, Yuan HB, Lee JR, Wise RJ, Handin RI. Interaction of the von Willebrand factor (VWF) with collagen - localization of the primary collagen-binding site by analysis of recombinant vWF A domain polypeptides. J Biol Chem 1995; 270: 10822-7.
12. van der Plas RM, Gomes L, Marquart JA, Vink T, Meijers JCM, de Groot PG, Sixma JJ, Huizinga EG. Binding of von Willebrand factor to collagen type III: Role of specific amino acids in the collagen binding domain of VWF and effects of neighboring domains. Thromb Haemost 2000; 84: 1005-11.
13. Vanhoorelbeke K, Depraetere H, Romijn RA, Huizinga EG, De Maeyer M, Deckmyn H. A consensus tetra-peptide selected by phage display adopts the conformation of a dominant discontinuous epitope of a monoclonal anti-VWF antibody that inhibits the VWF-collagen interaction. J Biol Chem 2003; 278: 37815-21.
14. Romijn RAP, Bouma B, Wuyster W, Gros P, Kroon J, Sixma JJ, Huizinga EG. Identification of the collagen-binding site of the von Willebrand factor A3-domain. J Biol Chem 2001; 276: 9985-91.
15. Romijn RA, Westein E, Bouma B, Schiphorst ME, Sixma JJ, Lenting PJ, Huizinga EG. Mapping the collagen-binding site in the von Willebrand factor-A3 domain. J Biol Chem 2003; 278: 15035-9.
16. Nishida N, Sumikawa H, Sakakura M, Shimba N, Takahashi H, Terasawa H, Suzuki EI, Shimada I. Collagen-binding mode of vWF-A3 domain determined by a transferred cross-saturation experiment. Nat Struct Biol 2003; 10: 53-8.
17. Huizinga EG, van der Plas RM, Kroon J, Sixma JJ, Gros P. Crystal structure of the A3 domain of human von Willebrand factor: Implications for collagen binding. Structure 1997; 5: 1147-56.
18. Matsui T, Hamako J, Matsushita T, Nakayama T, Fujimura Y, Titani K. Binding site on human von Willebrand factor of bitiscetin, a snake venom-derived platelet aggregation inducer. Biochemistry 2002; 41: 7939-46.
19. Maita N, Nishio K, Nishimoto E, Matsui T, Shikamoto Y, Morita T, Sadler JE, Mizuno H. Crystal structure of von Willebrand factor A1 domain complexed with snake venom, bitiscetin. Insight into glycoprotein Ibalpha binding mechanism induced by snake venom proteins. J Biol Chem 2003; 278: 37777-81.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970; 227: 680-5.
21. Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1, 3, 4, 6-tetrachloro-3a, 6a-diphenylglycoluril. Biochem Biophys Res Commun 1978; 80: 849-57.
22. Kalmakoff J, Parkinson AJ, Crawford AM, Williams BR. Solid phase radioimmunoassays using labelled antibodies: A conceptual framework for designing assays. J Immunol Methods 1977; 14: 73-84.
23. Matsui T, Hamako J, Suzuki M, Hayashi N, Ito M, Makita K, Fujimura Y, Ozeki Y, Titani K. Complete amino acid sequence of bitiscetin, a novel von Willebrand modulator protein purified from snake venom of Bitis arietans. Res Com Biochem Cell Mol Biol 1997; 1: 271-84.
24. Fujimura Y, Titani K, Usami Y, Suzuki M, Oyama R, Matsui T, Fukui H, Sigimoto M, Ruggeri ZM. Isolation and characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca. Biochemistry 1991; 30: 1957-64.